The second Biennial International Symposium on Ocular Regeneration brought together leaders in the fields of ophthalmology, genetics, stem cell biology, neuroregeneration, and neuroremodeling who aim to accelerate cures for blinding diseases. The event, held October 20, 2016 in Boston, MA, drew nearly 200 researchers, clinicians, trainees, and industry representatives from around the world.
Limbal stem cells -- identified with a new marker -- could reverse a leading cause of blindness
BOSTON (July 2, 2014) -- Boston researchers have identified a way to enhance regrowth of human corneal tissue to restore vision, using a molecule known as ABCB5 that acts as a marker for hard-to-find limbal stem cells. This work, a collaboration between the Massachusetts Eye and Ear/Schepens Eye Research Institute (Mass. Eye and Ear), Boston Children’s Hospital, Brigham and Women’s Hospital and the VA Boston Healthcare System, provides